Omnicell (NASDAQ:OMCL) reported quarterly earnings results on February 05, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $0.40, missing the consensus estimate of $0.41 by $0.01 per share. Revenue came in at $314.0M, beating the estimate of $313.4M.
Omnicell's stock moved following the earnings release. The stock currently trades at $38.50 with a market capitalization of $2.0B.